. . "203.28"^^ . "51999594"^^ . . "Schedule I"@en . "17"^^ . "Class B"@en . . . . . "139033209"^^ . "2384"^^ . . . . "YHB7YWS4WJ" . . . . "5-MBPB"@en . . "YHB7YWS4WJ"@en . . "1075459344"^^ . . . "13"^^ . "NpSG"@en . . . . . . "none"@en . . . "1"^^ . . . "CTEZPBCLIKEASW-UHFFFAOYSA-N"@en . . . . . "5-MBPB (also known as 5-MPBP and 5-MABB) is an amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia. 5-MBPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor."@en . . . "139033209" . . "52085237"^^ . "1"^^ . "1"^^ . "1"^^ . . "CCCNC"@en . . . "5-MBPB (also known as 5-MPBP and 5-MABB) is an amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia."@en . . . .